Representative Experience

• Diversicare Healthcare Services, Inc. Sold to DAC Acquisition LLC
  We represented Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a provider of long-term care services, in its sale to DAC Acquisition...
• Lead Counsel to POINT Biopharma Inc. in its SPAC Business Combination with Research Alliance Corp. I

  Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management.  Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.

• Heritage Global Inc. September 2020 Offering

  Representation of Heritage Global Inc. (Nasdaq: HGBL), an asset services company specializing in financial and industrial assets, in its public offering of 5,462,500 shares of common stock with proceeds of $9,559,375. The underwriters included Lake Street Capital Markets, LLC and Colliers Securities, LLC.

• LucidHealth Partners with Madison Radiologists

  Representation of LucidHealth, a portfolio company of Excellere Partners, in its acquisition of Madison Radiologists

• BioScrip and Option Care Complete Merger to Form Option Care Health

  We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

• NN, Inc. Common Stock Offering

  Represented NN, Inc. (Nasdaq: NNBR) in its public offering of 14,375,000 shares of common stock

• NN, Inc. Acquires Paragon Medical

  Represented NN, Inc. (Nasdaq: NNBR) in its acquisition of Paragon Medical

• LPS Integration Acquired by Data Blue

  Represented infrastructure technology solutions provider in its sell to Data Blue

• AmSurg Corp Merges with Envision Healthcare

  Represented AmSurg Corp. (NASDAQ: AMSG) in its merger with Envision Healthcare Holdings, Inc. (NYSE: EVHC)

• Luitpold Pharmaceuticals, Inc. Invests in BioMimetic Therapeutics, Inc.

  Advised BioMimetic Therapeutics, Inc. in the sale of its orofacial therapeutic business to Luitpold Pharmaceuticals, Inc.